ResearcherCharles UniversityNo recent work listed
David Hoskovec
Matched on ORCID iD 0000-0003-2948-8989; OpenAlex author ID A5055315336. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 10
2015: 2 papers · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper
Papers 4
- Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. Last author DOI 10.4149/neo_2023_230409n193↗
- Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience. Co-author DOI 10.4149/213_150611n326↗
- Pancreatic Cancer Diagnostics and Treatment--Current State. Co-author DOI 10.14712/23362936.2015.65↗
- [Irreversible electroporation in the treatment of locally advanced pancreatic cancer]. First author PMID 26767900↗
Closest collaborators
The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Z Krška · 4 shared papers, 2015–2023 · strength 0.37
- Paper Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.4149/neo_2023_230409n193↗
- Paper Pancreatic Cancer Diagnostics and Treatment--Current State. DOI 10.14712/23362936.2015.65↗
- Paper Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: genera… DOI 10.4149/213_150611n326↗
- Jan Ulrych · 2 shared papers, 2015–2023 · strength 0.24
- Lubos B. Petruzelka · 2 shared papers, 2016–2023 · strength 0.23
- Paper Chemotherapy versus chemoradiotherapy in borderline resectable and locally advanced pancreatic adenocarcinoma. DOI 10.4149/neo_2023_230409n193↗
- Paper Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: genera… DOI 10.4149/213_150611n326↗
- Pavel Záruba · 2 shared papers, 2015–2023 · strength 0.23
- Miroslav Ryska · 2 shared papers, 2015–2023 · strength 0.23
- Soňa Argalácsová · 1 shared paper, 2023 · strength 0.17
- Michal Vočka · 1 shared paper, 2023 · strength 0.17
- Jan Bříza · 1 shared paper, 2016 · strength 0.06
- Lukáš Lambert · 1 shared paper, 2016 · strength 0.06
- T Krechler · 1 shared paper, 2016 · strength 0.06
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.